Researchers identify lncRNA RPL34-AS1 as potential therapeutic target in esophageal cancer March 24, 2020
Innocare launches $288M IPO on HKEX, aims to advance BTK inhibitor March 23, 2020 By Elise Mak BEIJING – Cancer and autoimmune specialist Innocare Pharma Ltd., of Beijing, made a strong debut to raise $288 million on the Hong Kong Stock Exchange (HKEX) on March 23, marking the second biggest IPO in the city since the beginning of this year.Read More
RSS
